Kingfa Science net profit up 111% in Q1FY27 to ₹802 crore
Kingfa Science & Technology reported a 111% YoY rise in net profit to ₹802 crore in Q1FY27, while revenue grew 49% to ₹6,886 crore. EBITDA rose to ₹1,100 crore from ₹581 million, with the EBITDA margin expanding to 16.12% from 12.58%. Domestic sales, which accounted for 92% of total revenue, climbed to ₹6,349 crore, and sequential revenue grew 19% over Q4FY26.
*this image is generated using AI for illustrative purposes only.
Kingfa Science & Technology reported a substantial improvement in profitability for Q1FY27, with net profit rising to ₹802 crore compared to ₹380 crore in the corresponding period last year. The company's topline growth was equally robust, as revenue climbed 49% year-on-year to ₹6,886 crore from ₹4,619 crore. The results were approved by the Board of Directors at its meeting held on August 14, 2026, and published in newspaper advertisements on August 15–16, 2026.
Operating efficiency also strengthened during the period. EBITDA increased to ₹1,100 crore from ₹581 million, reflecting an expansion in operating leverage. The EBITDA margin widened to 16.12% from 12.58% in the prior year, indicating better cost management relative to sales volume.
Financial highlights
The following table summarises the key financial metrics for the quarter:
| Metric: | Q1FY27 | Q1FY26 | Change |
|---|---|---|---|
| Revenue: | ₹6,886 crore | ₹4,619 crore | +49.1% |
| EBITDA: | ₹1,100 crore | ₹581 million | +89.7% |
| EBITDA margin: | 16.12% | 12.58% | +354 bps |
| Net profit: | ₹802 crore | ₹380 crore | +111.1% |
Revenue breakdown
Domestic sales remained the primary growth driver, accounting for 92% of total revenue in Q1FY27. Domestic sales stood at ₹6,349 crore, up from ₹4,251 crore in Q1FY26. Export sales contributed 8% of the total, rising to ₹536 crore from ₹368 crore in the same period last year.
The company also reported a sequential increase in revenue. Total revenue from operations in Q1FY27 was ₹6,886 crore, compared to ₹5,785 crore in Q4FY26, representing a 19% quarter-on-quarter increase.
What the numbers show
The divergence between revenue growth (49%) and net profit growth (111%) highlights significant operating leverage. With EBITDA growing at nearly 90%, the company effectively translated higher sales into disproportionately higher earnings, driven by the expansion in EBITDA margin from 12.58% to 16.12%. This indicates that fixed costs were absorbed more efficiently as volumes scaled.
Earnings per share (basic) stood at ₹59.19 in Q1FY27, compared to ₹43.65 in Q4FY26. The total comprehensive income for the period was ₹803 crore.
Historical Stock Returns for Kingfa Science & Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.76% | -0.47% | +14.41% | +38.61% | +35.45% | +429.55% |
Can Kingfa sustain its expanded 16.12% EBITDA margin in Q2FY27, or is this improvement driven by one-off cost efficiencies?
How does the company plan to leverage its strong domestic revenue growth to accelerate its relatively smaller export segment?
What specific capital expenditure projects are funded by this surge in profitability, and how will they impact long-term capacity?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
